MedTech News
.................... by Andrew Celentano
Sleep could help identify people at risk of developing Alzheimer’s disease at an earlier stage
What if certain signs of the disease were to manifest subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège.
Elevation Spine lands FDA clearance for expandable interbody fusion system
Elevation’s FDA clearance for Saber-XA follows the agency’s clearance of its Saber-C AVIA cervical fixation device in July.
Acarix secures approval in UAE for CADScor system
Acarix will launch the CADScor system in the UAE through UniTech Solutions, which will manage regional distribu
Spineart Announces FDA Approval of BAGUERA® C Cervical Disc
GENEVA, Aug. 11, 2026 /PRNewswire/ — Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from cervical disc disease.
Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)
OKLAHOMA CITY, Aug. 10, 2026 /PRNewswire/ — Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way for commercial availability of the technology across the United Arab Emirates.
AI model maps tumor tissue to improve cancer care
A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently to the same therapy depending on how those cells are arranged. Spatial proteomics captures this organization in molecular detail, but the resulting data, which contain many different variables, are difficult to interpret and compare across studies.
Simple blood test on a chip could help diagnose lung cancer
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing.
Labcorp’s advanced melanoma CDx secures FDA approval
Labcorp’s CDx is designed to detect BRAF V600E and V600K melanoma mutations to determine which patients are eligible for BRAF inhibitor regimens.